These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8700565)
41. [Endocrine effects of doping with androgenic anabolic steroids]. Birkeland KI; Jørgensen J; Hemmersbach P Tidsskr Nor Laegeforen; 1994 Feb; 114(4):426-8. PubMed ID: 8009475 [TBL] [Abstract][Full Text] [Related]
42. Predictors of future anabolic androgenic steroid use. Wichstrøm L Med Sci Sports Exerc; 2006 Sep; 38(9):1578-83. PubMed ID: 16960518 [TBL] [Abstract][Full Text] [Related]
43. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran. Razavi Z; Moeini B; Shafiei Y; Bazmamoun H J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754 [TBL] [Abstract][Full Text] [Related]
44. Doping among high school students in Uppsala, Sweden: A presentation of the attitudes, distribution, side effects, and extent of use. Kindlundh AM; Isacson DG; Berglund L; Nyberg F Scand J Soc Med; 1998 Mar; 26(1):71-4. PubMed ID: 9526767 [TBL] [Abstract][Full Text] [Related]
45. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Rachoń D; Pokrywka L; Suchecka-Rachoń K Soz Praventivmed; 2006; 51(6):392-8. PubMed ID: 17658145 [TBL] [Abstract][Full Text] [Related]
46. Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins. Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS; Toli PN Eur Psychiatry; 2006 Dec; 21(8):563-9. PubMed ID: 16529916 [TBL] [Abstract][Full Text] [Related]
47. Anabolic androgenic steroids (AAS) as doping agents: chemical structures, metabolism, cellular responses, physiological and pathological effects. Fineschi V Mini Rev Med Chem; 2011 May; 11(5):359-61. PubMed ID: 21443515 [No Abstract] [Full Text] [Related]
48. Endocrine aspects of anabolic steroids. Wu FC Clin Chem; 1997 Jul; 43(7):1289-92. PubMed ID: 9216476 [TBL] [Abstract][Full Text] [Related]
55. [Anabolic androgenic steroids: a nightmare for control of doping or a drug?]. Stárka L Cas Lek Cesk; 1996 Mar; 135(5):131-4. PubMed ID: 8681352 [TBL] [Abstract][Full Text] [Related]
57. Current concepts in anabolic-androgenic steroids. Evans NA Am J Sports Med; 2004 Mar; 32(2):534-42. PubMed ID: 14977687 [TBL] [Abstract][Full Text] [Related]
58. Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis. Pozo OJ; De Brabanter N; Fabregat A; Segura J; Ventura R; Van Eenoo P; Deventer K Bioanalysis; 2013 Nov; 5(21):2661-77. PubMed ID: 24180506 [TBL] [Abstract][Full Text] [Related]
59. Development of anabolic-androgenic steroids purity certified reference materials for anti-doping. Quan C; Su F; Wang H; Li H Steroids; 2011 Dec; 76(14):1527-34. PubMed ID: 21925194 [TBL] [Abstract][Full Text] [Related]
60. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. Mulcahey MK; Schiller JR; Hulstyn MJ Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]